Under the agreement with Lilly, Celltrion will supply biologic drugs worth approximately 678.7 billion Won over three years through 2029.
https://news.nate.com/view/20260102n03230?mid=n1101
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.